AEC-Amersham SOC Ltd
AEC-Amersham SOC Ltd, is a wholly owned subsidiary of NTP Radioisotopes and provides quality products and services for Healthcare, Life Sciences and Quality and Safety Assurance market segments.
Transforming Healthcare Through Precision Radiopharmaceuticals
We are a pioneering leader in the development, manufacturing, and distribution of radiopharmaceuticals—advanced nuclear medicine solutions that enable earlier diagnosis, targeted treatment, and personalized patient care. By harnessing the power of radioactive isotopes, we empower healthcare providers to detect, monitor, and treat diseases with unprecedented accuracy, improving outcomes and saving lives.
Our Core Services
Illuminating disease at the molecular level for early and precise detection.
- PET & SPECT Tracers: High-purity isotopes (e.g., ¹⁸F-FDG, ⁹⁹ᵐTc) for oncology, cardiology, and neurology imaging.
- Innovative Probes: Custom-developed tracers for emerging biomarkers and research applications.
- Kit Formulations: Ready-to-use, GMP-compliant kits for streamlined clinical workflows.
Delivering targeted radiation to destroy cancer cells while sparing healthy tissue.
- Targeted Radionuclide Therapy (TRT): Alpha- and beta-emitting isotopes (e.g., ¹⁷⁷Lu, ²²⁵Ac) for precision oncology.
- Radioimmunotherapy: Antibody-guided isotopes for hematologic and solid tumors.
- Theranostic Pairs: Integrated diagnostic/therapeutic solutions (e.g., PSMA, DOTATATE) for personalized treatment planning.
Pioneering next-generation radiopharmaceuticals to address unmet medical needs.
- Isotope Innovation: Novel radiolabeling techniques and isotope production (cyclotron/generator-based).
- Preclinical Studies: Collaborative R&D for new tracers, formulations, and delivery systems.
- Clinical Trial Support: GMP manufacturing and regulatory guidance for investigational drugs.
Ensuring reliable, scalable, and compliant access to critical radiopharmaceuticals.
- GMP Production: State-of-the-art facilities for sterile, high-purity radiopharmaceutical synthesis.
- Global Distribution: Temperature-controlled logistics with real-time tracking for short-lived isotopes.
- On-Demand Manufacturing: Just-in-time production to maximize isotope utilization and reduce waste.
Upholding the highest standards of safety, efficacy, and compliance.
- Regulatory Strategy: Expertise in FDA/EMA approvals, licensing, and pharmacovigilance.
- Quality Control: Rigorous testing for purity, sterility, and radiochemical stability.
- Compliance Support: Audits, documentation, and training for nuclear pharmacies and hospitals.
Empowering healthcare teams with expertise and education.
- Training Programs: Hands-on workshops for safe handling, administration, and imaging protocols.
- Dose Optimization: Personalized dosimetry and treatment planning software.
Why Partner With Us?
- Scientific Excellence: Led by experts in nuclear medicine, radiochemistry, and oncology.
- Innovation-Driven: Investing in breakthrough isotopes, AI-enhanced imaging, and theranostics.
- Patient-Centric Focus: Solutions designed to improve survival rates, reduce side effects, and enhance quality of life.
- Global Reach: Reliable supply chain across 50+ countries with local regulatory expertise.
- Sustainability: Eco-friendly isotope production and waste minimization practices.
Our Commitment
We bridge the gap between cutting-edge science and life-changing patient care. From accelerating cancer diagnosis to enabling targeted tumor destruction, our radiopharmaceuticals represent the future of precision medicine. Together with healthcare partners worldwide, we are redefining what’s possible in disease management.
Discover how our radiopharmaceuticals can elevate your clinical practice.